Ultragenyx Pharmaceutical Inc. buy Morgan Stanley
Start price
09.05.25
/
50%
€31.20
Target price
09.05.26
€57.96
Performance (%)
-33.33%
Price
15.01.26
€20.60
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc. is performing very badly with a performance of -33.33%. This prediction currently runs until 09.05.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 4.040% | 4.040% |
| iShares Core DAX® | 0.336% | 4.366% |
| iShares Nasdaq 100 | 0.541% | 3.170% |
| iShares Nikkei 225® | 4.048% | 6.727% |
| iShares S&P 500 | 0.795% | 3.281% |
Comments by Morgan_Stanley for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Morgan Stanley from $64.00 to $65.00. They now have an "overweight" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Morgan_Stanley for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€24.00
14.07.25
14.07.25
€47.06
14.07.26
14.07.26
-13.33%
15.01.26
15.01.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€36.60
03.11.23
03.11.23
€78.49
03.11.24
03.11.24
30.05%
04.11.24
04.11.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
10.10.23
10.10.23
€84.74
10.10.24
10.10.24
43.02%
11.10.24
11.10.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.60
04.08.23
04.08.23
€86.28
04.08.24
04.08.24
30.06%
05.08.24
05.08.24